{"Abstract": [0], "Human": [1], "coronaviruses": [2], "(HCoVs),": [3], "including": [4], "severe": [5], "acute": [6], "respiratory": [7], "syndrome": [8], "coronavirus": [9, 14], "(SARS-CoV)": [10], "and": [11, 26, 53, 88, 119, 135, 148, 165, 177, 199, 245], "2019": [12], "novel": [13], "(2019-nCoV,": [15], "also": [16], "known": [17], "as": [18, 40], "SARS-CoV-2),": [19], "lead": [20], "global": [21], "epidemics": [22], "with": [23, 113], "high": [24], "morbidity": [25], "mortality.": [27], "However,": [28], "there": [29], "are": [30, 124, 168], "currently": [31], "no": [32], "effective": [33, 42], "drugs": [34, 161, 215, 244], "targeting": [35, 249], "2019-nCoV/SARS-CoV-2.": [36, 250], "Drug": [37], "repurposing,": [38], "representing": [39], "an": [41, 68], "drug": [43, 61, 71, 89, 146, 190, 247], "discovery": [44], "strategy": [45], "from": [46], "existing": [47], "drugs,": [48], "could": [49], "shorten": [50], "the": [51, 55, 82, 85, 92, 108, 117, 130, 152, 205, 211, 214, 218, 226], "time": [52], "reduce": [54], "cost": [56], "compared": [57, 138], "to": [58, 139], "de": [59], "novo": [60], "discovery.": [62], "In": [63, 230], "this": [64, 232], "study,": [65], "we": [66, 155], "present": [67], "integrative,": [69], "antiviral": [70], "repurposing": [72], "methodology": [73], "implementing": [74], "a": [75], "systems": [76], "pharmacology-based": [77], "network": [78, 142], "medicine": [79], "platform,": [80], "quantifying": [81], "interplay": [83], "between": [84], "HCoV\u2013host": [86, 149, 219], "interactome": [87, 228], "targets": [90, 147, 212], "in": [91, 151, 181, 225], "human": [93, 153, 182, 227], "protein\u2013protein": [94], "interaction": [95], "network.": [96, 229], "Phylogenetic": [97], "analyses": [98, 144, 173], "of": [99, 122, 133, 145, 174, 213, 241], "15": [100], "HCoV": [101], "whole": [102], "genomes": [103], "reveal": [104], "that": [105, 167], "2019-nCoV/SARS-CoV-2": [106, 123], "shares": [107], "highest": [109], "nucleotide": [110], "sequence": [111, 131], "identity": [112], "SARS-CoV": [114], "(79.7%).": [115], "Specifically,": [116], "envelope": [118], "nucleocapsid": [120], "proteins": [121], "two": [125], "evolutionarily": [126], "conserved": [127], "regions,": [128], "having": [129], "identities": [132], "96%": [134], "89.6%,": [136], "respectively,": [137], "SARS-CoV.": [140], "Using": [141], "proximity": [143], "interactions": [150], "interactome,": [154], "prioritize": [156], "16": [157], "potential": [158, 189, 246], "anti-HCoV": [159], "repurposable": [160, 243], "(e.g.,": [162, 192], "melatonin,": [163, 198], "mercaptopurine,": [164], "sirolimus)": [166], "further": [169, 186], "validated": [170], "by": [171, 204], "enrichment": [172], "drug-gene": [175], "signatures": [176], "HCoV-induced": [178], "transcriptomics": [179], "data": [180], "cell": [183], "lines.": [184], "We": [185], "identify": [187], "three": [188], "combinations": [191, 248], "sirolimus": [193], "plus": [194, 197, 201], "dactinomycin,": [195], "mercaptopurine": [196], "toremifene": [200], "emodin)": [202], "captured": [203], "\u201c": [206], "Complementary": [207], "Exposure": [208], "\u201d": [209], "pattern:": [210], "both": [216], "hit": [217], "subnetwork,": [220], "but": [221], "target": [222], "separate": [223], "neighborhoods": [224], "summary,": [231], "study": [233], "offers": [234], "powerful": [235], "network-based": [236], "methodologies": [237], "for": [238], "rapid": [239], "identification": [240], "candidate": [242]}